Scientific Founder, Prof. Antonio Bertoletti and Scientific Consultant, Dr Anthony Tanoto Tan of LION TCR were awarded the SingHealth Duke-NUS Research Award 1st Prize 2018 February 12, 2018Researchinfo@liontcr.com
US FDA grants Lion TCR two orphan drug designations of T cell therapy against Hepatocellular Carcinoma August 21, 2017Press Releaseinfo@liontcr.com
Breakthrough immunotherapy for Chronic Hepatitis B virus infection August 25, 2017Press Release, Researchinfo@liontcr.com
Dr. Antonio Bertoletti speaks at the World Life Science Conference 2016 January 25, 2017Eventsinfo@liontcr.com
Scientific Director, Dr. Sarene Koh, speaks at the 1st Transmed-VN Conference January 25, 2017Eventsinfo@liontcr.com
Dr. Antonio Bertoletti presents Lion TCR T-cell therapy at the International Society for Cellular Therapy Conference 2016 January 25, 2017Eventsinfo@liontcr.com
New publication – Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. January 25, 2017Researchinfo@liontcr.com
